Hypoxia stimulates the expression of macrophage migration inhibitory factor in human vascular smooth muscle cells via HIF-1α dependent pathway
- 6.1k Downloads
Hypoxia plays an important role in vascular remodeling and directly affects vascular smooth muscle cells (VSMC) functions. Macrophage migration inhibitory factor (MIF) is a well known proinflammatory factor, and recent evidence suggests an important role of MIF in the progression of atherosclerosis and restenosis. However, the potential link between hypoxia and MIF in VSMC has not been investigated. The current study was designed to test whether hypoxia could regulate MIF expression in human VSMC. The effect of modulating MIF expression on hypoxia-induced VSMC proliferation and migration was also investigated at the same time.
Expression of MIF mRNA and protein was up-regulated as early as 2 hours in cultured human VSMCs after exposed to moderate hypoxia condition (3% O2). The up-regulation of MIF expression appears to be dependent on hypoxia-inducible transcription factor-1α(HIF-1α) since knockdown of HIF-1α inhibits the hypoxia induction of MIF gene and protein expression. The hypoxia induced expression of MIF was attenuated by antioxidant treatment as well as by inhibition of extracellular signal-regulated kinase (ERK). Under moderate hypoxia conditions (3% O2), both cell proliferation and cell migration were increased in VSMC cells. Blocking the MIF by specific small interference RNA to MIF (MIF-shRNA) resulted in the suppression of proliferation and migration of VSMCs.
Our results demonstrated that in VSMCs, hypoxia increased MIF gene expression and protein production. The hypoxia-induced HIF-1α activation, reactive oxygen species (ROS) generation and ERK activation might be involved in this response. Both MIF and HIF-1α mediated the hypoxia response of vascular smooth muscle cells, including cell migration and proliferation.
KeywordsVascular Smooth Muscle Cell Migration Inhibitory Factor Migration Inhibitory Factor Expression Hypoxia Stimulation Human VSMCs
Tissue hypoxia is an essential feature of chronic inflammatory diseases. In the cardiovascular system, for example, when arterial wall thickens and blood-diffusion capacity is low in atherosclerotic lesions, hypoxia plays a key role in the development of atherosclerosis [1, 2]. The cellular effects of hypoxia are primarily mediated by the hypoxia-inducible transcription factor-1 (HIF-1). It is a heterodimeric transcription factor composed of α and β subunits. HIF-1β is constitutively expressed in many cell types. HIF-1α, the active subunit of HIF-1, is undetectable under normoxia because of rapid proteasomal degradation. But it is stabilized under hypoxia conditions . HIF-1 specifically binds hypoxic response element (HRE)-driven promoters on a number of genes such as vascular endothelial growth factor (VEGF), heme oxygenase and erythropoietin. In human atherosclerosis, HIF-1α protein co-localizes with macrophages . HIF-1α may play a role in foam cell formation . Evidences suggest that the HIF-1 pathway is associated with the progression and angiogenesis of human atherosclerosis [2, 5, 6]. Recent studies have shown that in normal oxygen conditions, G-protein-coupled receptor agonists including angiotensin II [7, 8] and thrombin , potently induce and activate HIF-1α in vascular smooth muscle cells. These results suggest a more general role of this transcription factor in the vascular response to injury. However, the role of hypoxia and HIF-1 in atherosclerosis remains largely unknown.
Recently, macrophage migration inhibitory factor (MIF) has emerged as a key factor in vascular remodeling and in the development and progression of atherosclerosis [10, 11, 12, 13]. MIF is an essential, upstream component of the inflammatory cascade and has a critical role in several inflammatory conditions . It can be expressed by vascular endothelial cells, VSMCs and macrophages. Increased expression of vascular MIF is associated with foam cell transformation during atherogenesis. MIF is expressed in atherosclerotic lesions, and has been suggested to be involved in atherosclerotic plaque development . Several pro-atherosclerotic mediators such as oxidized LDL , CD40-L and angiotensin II are able to stimulate MIF expression . However, the regulation of MIF expression in vascular cells, and its mechanisms of action have received little attention in atherosclerosis research.
MIF has recently been shown to be up-regulated by hypoxia in several tumor cell types in vitro including breast carcinoma cells [15, 16]. However, there are few data about the direct effects of hypoxia on the expression of MIF in VSMCs. VSMCs are one of the major constituents of blood vessels. VSMCs are also essential to atherosclerotic lesions. In the view of the increased expression of MIF in the atherosclerosis, we hypothesized that MIF might be up-regulated by hypoxia in VSMCs, and the up-regulation of MIF could be mediated via HIF-1 dependent pathway. In order to test our hypothesis, we examined the influence of hypoxia on the MIF expression in human VSMCs. Primary human umbilical artery smooth muscle cells (HUASMCs) were used as a model to study the effects of hypoxia on the expression of MIF modulated by RNA interference in this study.
Hypoxia increases MIF expression in cultured vascular smooth muscle cells
It was reported that hypoxia (1% O2) stimulation could induce MIF expression in breast cancer cell line . However, exposure to hypoxia (1% O2) reduced cell proliferation and increased apoptotic cell death in VSMC . Therefore, in our present study, in order to test the effect of hypoxia on the MIF expression, different degrees of hypoxia (10, 5, or 3% O2, but not 1% O2) were used.
We next examined whether MIF protein production was regulated in response to hypoxia by Western Blot and ELISA. The cells were exposed to hypoxia for indicated times. Subsequently, the secretion of MIF in the culture media was measured by ELISA. Under normoxia condition, growth-arrested HUASMCs expressed low level of MIF protein. Our data showed that 3% oxygen induced maximum MIF protein expression at 24 h (Figure 1B). Similarly, under normoxia condition, HUASMCs only expressed low level MIF protein as detected by Western blot. Total cellular MIF protein levels began to increase 2 h after exposure to 3% O2, and peaked at 24 h (Figure 1C). These data suggest that hypoxia induces both MIF mRNA and protein production in HUASMCs.
Hypoxia stimulation (3% O2) induces expression and activation of HIF-1α in cultured vascular smooth muscle cells
In order to further validate that HIF-1α could be activated by the hypoxia stimulation (3% O2), we next performed electrophoretic mobility shift assay (EMSA) experiments aimed at assessing whether HIF-1α DNA binding activity can be induced under 3% O2 hypoxia conditions. EMSA assay was performed using primers encompassing the hypoxia response element (HRE) and adjacent flanking regions in the promoter of human MIF gene . Our data showed that HIF-1α binding activity could be increased by exposure to hypoxia (3% O2) for 24 h (Figure 2C).
The hypoxia-induced MIF expression in cultured vascular smooth muscle cells is dependent on HIF-1α pathway
Molecular mechanisms of hypoxia-induced HIF-1α and MIF expression in HUASMCs
Hypoxia activates several intracellular mediators, such as intracellular reactive oxygen species (ROS) [9, 20] and extracellular signal-regulated kinase(ERK). Hypoxia-induced HIF-1α expression and activation was blocked by treatment with antioxidant Tiron (4, 5-dihydroxy-1,3-benzene disulfonic acid, a widely used antioxidant), and PD98059 (inhibitor of ERK signaling)(Figure 2), indicating that activation of ERK signaling and reactive oxygen species generated in response to hypoxia are essential in this process.
Role of MIF in the hypoxia-induced proliferation of HUASMCs
In order to examine if MIF plays a role in hypoxia-induced cell proliferation, we used bromodeoxyuridine (Brdu) incorporation assay[22, 23] to study the proliferation of growth-arrested HUASMCs followed by co-treatment with specific MIF-siRNA (Santa Cruz Biotech, USA) and hypoxia (3% O2) for 24 h. The specific MIF-siRNA could significantly inhibit MIF expression in HUVSMCs under both normoxia and hypoxia conditions (Figure 5).
Role of MIF in hypoxia-induced migration in HUVSMCs
To examine the effect of MIF in VSMC migration in response to hypoxia, HUASMCs were incubated in a Boyden chamber under normoxic or hypoxic conditions, in the absence or presence of specific siRNA to MIF (MIF-siRNA). As shown in Figure 6B, HUASMCs migrated significantly through the filter membrane under hypoxia (3% O2) for 24 h. The MIF-siRNA partly prevented this increase in cell migration both under hypoxia (27.7% inhibition) and in normoxia (47.7% inhibition). Over-expression of HIF-1α could enhance the HUASMC migration under normoxia, whereas knockdown of HIF-1α expression in HUASMCs abolished hypoxia-induced migration in these cells. Our data demonstrate that MIF not only involves in controlling the baseline migration in normoxia condition, but also mediates migration of VSMC in response to hypoxia.
In the present study, the potential correlation between hypoxia and MIF expression was investigated in cultured HUASMCs. The major findings of this study are: (1) hypoxia at 3% O2, but not 5 or 10% oxygen, up-regulates MIF expression in VSMCs; (2) transcription factor HIF-1α is necessary and sufficient in the signaling pathway of MIF induction under hypoxia; (3) enhanced generation of reactive oxygen species (ROS) and activation of extracellular signal-regulated kinase (ERK) might be important in mediating the hypoxia-induced expression of HIF-1α and MIF; (4) blockade of MIF results in the inhibition of hypoxia-induced proliferation and migration in the HUASMC cells. Our data clearly indicate that moderate hypoxia plays a crucial role in the modulation of MIF expression in VSMCs. These observations also establish a role of MIF in mediating hypoxia-induced proliferation and migration in vascular smooth muscle cells. In addition, our results suggest that inhibition of MIF might be useful for preventing abnormal VSMC proliferation and migration evoked by hypoxia.
Both MIF and hypoxia play critical roles in inflammation and atherosclerosis. MIF has been identified as a hypoxia-induced gene in cancer cells. Recent evidences show that MIF is up-regulated by hypoxia (1% O2) in human cancer cells, such as colon tumor cells and breast carcinoma cells . Moreover, MIF mRNA expression is induced in a HIF-dependent manner in HeLa cells . However, by using siRNA approach, Larsen et al reported that MIF regulation in MCF-7 breast cancer cells is due to other hypoxia-induced regulatory mechanisms, independent of HIF-1 and HIF-2 activation. Consistent with previous report , we observed that HIF-1α mRNA and protein expression and DNA binding activity could be induced in HUASMCs exposed to hypoxia stimulation (3% O2). In our experimental model, over-expression of HIF-1α, the key transcription factor activated during hypoxia, was able to up-regulate MIF gene and protein expression under normoxia, whereas knockdown of HIF-1α expression in HUASMCs inhibited hypoxia-induced MIF expression. Our data demonstrate that, in cultured HUASMCs, hypoxia (3% O2) increased MIF expression and synthesis via the HIF-1α pathway, suggesting that the mechanism involved in up-regulation of MIF expression is dependent on cell type.
HIF-1 regulation by non-hypoxic stimuli has gained considerable interest [8, 9]. In addition to angiotensin II and thrombin , studies have showed that HIF-1α stabilization and activation is also induced by several pro-inflammatory cytokines, such as IL-1 and TNFα [25, 26]. As a regulator of MIF expression, HIF-1α might be of potential importance during inflammatory diseases. It is reported that MIF regulates HIF-1 activity in a p53-dependent manner in human cancer cells. Therefore, whether MIF could activate HIF-1α transcriptional activity in VSMCs needs further studies.
Activation of several signaling pathways such as ERK might mediate HIF-1α activation  and MIF expression . By using a specific inhibitor, the present observations demonstrate that hypoxia upregulates MIF via activation of ERK in HUVSMCs. Another pathway implicated in the hypoxia induced response is the generation of intercellular ROS [9, 20]. Our results showed that the antioxidant Tiron, a cell permeable scavenger of ROS, partially blocks MIF production elicited by hypoxia, suggesting that ROS acts as intermediates of hypoxia-induced MIF expression.
VSMCs proliferation and migration that respond to vascular injury contribute to vessel narrowing and play an important role in the atherosclerotic process. It has been recognized that hypoxia is a stimulus to VSMCs proliferation and migration, a process known as the vascular remodeling [29, 30]. Hypoxia plays an important role in vascular remodeling and directly affects VSMCs functions. Some growth factors, such as PDGF  and VEGF , are involved in the hypoxia-induced proliferation of VSMCs. Consistent with previous reports [23, 31], we observed that HIF-1α is essential to VSMC proliferation exposed to hypoxia. Moreover, our results show that the specific MIF-siRNA partially blocks HUASMCs proliferation elicited by hypoxia, suggesting that MIF acts as one of the mediators of hypoxia-induced VSMC proliferation.
In addition to proliferation of VSMCs within the vessel wall, the migration of VSMCs from the media into the neointima is another important feature in the pathogenesis of atherosclerosis [5, 32, 33]. This process is regulated by multiple factors, and MIF is one of the multiple factors that could increase VSMCs migration. MIF is an important mediator of vessel wall remodeling and acts on the migration of VSMCs in an autocrine and paracrine manner. Previous report shows that hypoxia induces the migration of human coronary artery smooth muscle cells, and the migration is elicited by thrombospondin-1. In the present study, treatment of HUASMCs with the specific MIF-siRNA abolished hypoxia-induced migration, suggesting a role for MIF in the migration of VSMCs in response to hypoxia. Altogether, our data demonstrate that HIF-1α and MIF are both important mediators of vascular cell proliferation and migration.
In summary, we showed that hypoxia, and specifically HIF-1α, might be a potent and rapid inducer of MIF expression in human VSMCs. The specific MIF-siRNA could suppress both basal and hypoxia-induced proliferation and migration of VSMCs. In view of the important role of MIF and hypoxia to atherosclerosis, our findings might contribute to the understanding of the pathogenesis of progressive atherosclerosis.
Vascular smooth muscle cell culture
Primary cultures of HUASMCs were isolated from freshly delivered umbilical cords by tissue explanting method [35, 36] and maintained in DMEM medium (GIBCO-BRL) supplemented with 20% fetal bovine serum (FBS) (Hyclone), 2 mmol/L L-glutamine, and 1% penicillin-streptomycin. All cell cultures were maintained in a humidified 5% CO2/95% air incubator at 37°C. When confluent, HUASMCs were passaged every 6-7 days after trypsinization and were used for experiment from the third to sixth passages. HUASMCs were identified by the specific marker of vascular smooth muscle cell (α-smooth muscle actin, α-SMA) immunofluorescence.
The study was conducted according to the Declaration of Helsinki. The study was reviewed and approved by the medical ethics committee of the West China Hospital, Sichuan University.
A humidified temperature controlled incubator model IG 750 (Jouan, Saint-Nazaire, France) was used as a hypoxic chamber. For hypoxia conditions, the concentration of oxygen was reduced to 10, 5, or 3% by replacement with N2, and CO2 was constant at 5%. Control was defined as 95% air and 5% CO2.
HUASMCs were seeded in the 60 mm plates (Corning, NY, USA). All cells were grown to 90% confluence under normoxic conditions. The media was then changed, pretreated in starving conditions (normal culture media without FBS) for 24 h before exposure to hypoxia. Experiments were carried out with three replicates for each data point. In some experiments, cells were pre-treated for 30 minutes with 10-6 mol/L PD98059, or 5×10-3 mol/L Tiron, and then exposed to hypoxia for 24 h.
HIF-1α target-specific siRNA plasmid vector and a scrambled siRNA control plasmid were constructed as our previously described . Constructs expressing HIF-1α (wild type) were a gift from Professor Cormac T. Taylor (University College, Dublin, Ireland). Transient transfections were performed using the cationic lipid, Lipofectamine™ 2000 (Invitrogen, USA), according to the manufacturer's protocols. Cells were plated in dishes (60 mm in diameter) grown to 90% confluence prior to transfection. Each dish was transfected with 8.0 μg of plasmid containing HIF siRNA or control RNA (plasmids containing null mutant HIF-GFP) and 20 μL of Lipofectamine™ 2000. Wild type HIF-1α was co-transfected with EGFP. Transfection efficiency averaged between 60-70% as measured by green fluorescent protein expression. Cells were allowed to recover in DMEM for 6 h after transfection. After the medium changed, the culture was exposed to normoxia or hypoxia for 24 h before assays were performed.
In some experiments, cultured HUASMCs were transfected with 800 ng siRNA duplex specific to MIF (MIF-siRNA) (Santa Cruz Biotech, USA) according to the manufacturer's instruction.
The expression of MIF gene was identified by quantitative real time RT-PCR (Q-PCR) as reported earlier . Total RNA was extracted from HUASMCs cells using TRIZOL® reagent (Invitrogen, USA). Q-PCR was carried out on an ABI Prism 7300 PCR Detection System (Applied Biosystems, USA) with fluorescence dye SYBR Green (SYBR Green Real-time PCR Master Mix, TOYOBO, Japan). The sequences of the primers were as follows: MIF-F: 5'-GTGCCAGAGGGGTTTCTCTC-3', MIF-R: 5'-CAGCAGCTTGCTGTAGTTGC-3'. HIF-1α-F: 5'-CTAGCCGAGGAA GAACTATGAACAT-3', HIF-1α-R: 5'-CTGAGGTTGGTTACTGTT GGTATCA-3'. β-actin-F: 5'-CAACTCCATCATGAAGTGTAAC-3'; β-actin-R: 5'-CCACACGGA GTACTTGCGCTG-3'. The thermal cycling conditions were as following: 95°C 60 seconds, 40 cycles of 95°C for 15 seconds, 58°C for 15 seconds, 72°C for 45 seconds (data collection). Data analysis was carried out by ABI sequence detection software using relative quantification. For quantification, the target sequence was normalized to the β-actin mRNA levels.
Western Blot Analysis
Western-blot analysis of MIF and HIF-1α was performed using rabbit polyclonal antibodies against MIF or HIF-1α (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), according to the method described before [38, 39]. In brief, HUASMC cells were scraped from dishes and cellular protein extracts were prepared by homogenization in an ice-cold RIPA lysis buffer containing protease inhibitor cocktail (Roche, Indianapolis, IN, USA). Cell lysates (40 μg) were separated by denaturing 10% SDS-PAGE and then transferred to polyvinylidene difluoride (PVDF) membrane (Millipore) using a MiniProtein III system (Bio-Rad, CA, USA). Transferred proteins were probed with the rabbit polyclonal anti-MIF or anti-HIF-1α antibody (1:250) and visualized using the horseradish peroxidase conjugated secondary anti-rabbit (1:3000; Santa Cruz Biotechnology, Inc) antibody and ECL solution (Pierce, USA). Equal protein loading was verified by reprobing the membrane with an anti β-actin antibody (Santa Cruz Biotechnology, Inc.). For quantification purposes, densitometry measurements were performed using Quantity One® image analysis software for Windows (Bio-Rad). All specific blot values were corrected for β-actin expression.
Quantification of MIF by ELISA
The level of MIF in culture supernatants was measured by ELISA using ELISA kit (Quantikine ELISA, R&D Systems, USA) according to manufacturer's instructions [15, 38]. In each experiment the MIF concentrations was normalized to cell count.
Preparation of Nuclear Extracts and Electrophoretic Mobility Shift Assay
Nuclear extracts from HUASMCs were prepared according to standard protocols . Electrophoretic mobility shift assay (EMSA) was performed as described , using a 24-bp oligonucleotide probe containing the HRE with the HIF-1α binding site and adjacent flanking regions of human MIF gene . The probe was as follows: 5'-TCTGT ACGTG ACCACACTCACCTC-3' (The consensus core HIF-1α binding sites are boldfaced).
Assessment of cell proliferation
The effect of hypoxia on cell proliferation was determined by the bromodeoxyuridine (BrdU) incorporation assay, as described previously [22, 23]. Briefly, HUASMC cells were subcultured in 96-well plates and incubated with serum-free medium for 24 h in order to synchronize the cells in G0/G1 phase. Quiescent cells were transfected with wild type HIF-1α, HIF-1α-shRNA, MIF-shRNA or scrambled siRNA for 24 hours, and then either exposed to normoxia or hypoxia for 24 h. 10 μL of BrdU (100 μM) was added to each well and incubated for the last 3 h of treatment. BrdU incorporation was measured by a colorimetric ELISA kit (Roche, Indianapolis, IN, USA). The light absorbance at 450 nm was detected using ELISA reader (Bio-Rad Model 680, USA).
Cell Migration Assay
The migration of HUASMCs was determined by using a Matrigel chamber system (BD Biosciences) as previous reports [34, 40]. Briefly, HUASMC cells were incubated with serum-free medium for 24 h. Quiescent cultures were transfected with wild type HIF-1α, HIF-1α-siRNA, MIF-siRNA or scrambled siRNA for 24 h. Following transfection, HUASMCs (1×104) were suspended in 0.5 ml of culture medium and added to the upper chamber. The upper chamber was lodged into the lower chamber containing 0.75 ml of culture medium. After incubating at 37°C for 24 h under normoxia or hypoxia conditions, the cells in the upper side of the filter membrane were removed with cotton swabs. Then the cells in the lower side were trypsinized, and the number of cells in the lower side was counted.
The experimental data were expressed as means ± SD. Group means were compared by ANOVA using the statistical software program SPSS 10.0 for Windows (Chicago, IL, USA), and P value < 0.05 was considered statistically significant in all cases.
This work was supported by grants from Natural Science Foundation of China, No. 30470437, 30870598(Xiaojing Liu), No. 30871118, 30971325 (Fengming Luo), the projects of Science and Technology Bureau of Sichuan Province No.2008FZ0156 (Hua Fu), No. 2009FZ0097 (Li Yang), the project of Science and Technology Bureau of Chengdu No. 2008-10(Hua Fu) and grants from Ministry of Education of the people's Republic of China, No. NCET-08-0374, 20091001-9-3 (Fengming Luo). We would like to acknowledge the assistance and critical advice provided by Dr. Jue Lin (University of California, San Francisco) and Dr. Rui Lin (Exelixis, Inc. USA) in the preparation of this manuscript.
- 1.Nakano D, Hayashi T, Tazawa N, Yamashita C, Inamoto S, Okuda N, Mori T, Sohmiya K, Kitaura Y, Okada Y, Matsumura Y: Chronic hypoxia accelerates the progression of atherosclerosis in apolipoprotein E-knockout mice. Hypertens Res. 2005, 28 (10): 837-845. 10.1291/hypres.28.837.CrossRefPubMedGoogle Scholar
- 2.Sluimer JC, Gasc JM, van Wanroij JL, Kisters N, Groeneweg M, Sollewijn Gelpke MD, Cleutjens JP, van den Akker LH, Corvol P, Wouters BG, Daemen MJ, Bijnens AP: Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. J Am Coll Cardiol. 2008, 51 (13): 1258-1265. 10.1016/j.jacc.2007.12.025.CrossRefPubMedGoogle Scholar
- 3.Nishi K, Oda T, Takabuchi S, Oda S, Fukuda K, Adachi T, Semenza GL, Shingu K, Hirota K: LPS induces hypoxia-inducible factor 1 activation in macrophage-differentiated cells in a reactive oxygen species-dependent manner. Antioxid Redox Signal. 2008, 10 (5): 983-995. 10.1089/ars.2007.1825.CrossRefPubMedGoogle Scholar
- 9.Gorlach A, Diebold I, Schini-Kerth VB, Berchner-Pfannschmidt U, Roth U, Brandes RP, Kietzmann T, Busse R: Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22(phox)-containing NADPH oxidase. Circ Res. 2001, 89 (1): 47-54. 10.1161/hh1301.092678.CrossRefPubMedGoogle Scholar
- 10.Verschuren L, Kooistra T, Bernhagen J, Voshol PJ, Ouwens DM, van Erk M, de Vries-van der Weij J, Leng L, van Bockel JH, van Dijk KW, Fingerle-Rowson G, Bucala R, Kleemann R: MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease. Circ Res. 2009, 105 (1): 99-107. 10.1161/CIRCRESAHA.109.199166.PubMedCentralCrossRefPubMedGoogle Scholar
- 12.Schmeisser A, Marquetant R, Illmer T, Graffy C, Garlichs CD, Bockler D, Menschikowski D, Braun-Dullaeus R, Daniel WG, Strasser RH: The expression of macrophage migration inhibitory factor 1alpha (MIF 1alpha) in human atherosclerotic plaques is induced by different proatherogenic stimuli and associated with plaque instability. Atherosclerosis. 2005, 178 (1): 83-94. 10.1016/j.atherosclerosis.2004.08.038.CrossRefPubMedGoogle Scholar
- 15.Larsen M, Tazzyman S, Lund EL, Junker N, Lewis CE, Kristjansen PE, Murdoch C: Hypoxia-induced secretion of macrophage migration-inhibitory factor from MCF-7 breast cancer cells is regulated in a hypoxia-inducible factor-independent manner. Cancer Lett. 2008, 265 (2): 239-249. 10.1016/j.canlet.2008.02.012.CrossRefPubMedGoogle Scholar
- 22.Redondo S, Ruiz E, Gordillo-Moscoso A, Navarro-Dorado J, Ramajo M, Carnero M, Reguillo F, Rodriguez E, Tejerina T: Role of TGF-beta1 and MAP kinases in the antiproliferative effect of aspirin in human vascular smooth muscle cells. PLoS One. 2010, 5 (3): e9800-10.1371/journal.pone.0009800.PubMedCentralCrossRefPubMedGoogle Scholar
- 24.Yao K, Shida S, Selvakumaran M, Zimmerman R, Simon E, Schick J, Haas NB, Balke M, Ross H, Johnson SW, O'Dwyer PJ: Macrophage migration inhibitory factor is a determinant of hypoxia-induced apoptosis in colon cancer cell lines. Clin Cancer Res. 2005, 11 (20): 7264-7272. 10.1158/1078-0432.CCR-05-0135.CrossRefPubMedGoogle Scholar
- 26.Frede S, Freitag P, Otto T, Heilmaier C, Fandrey J: The proinflammatory cytokine interleukin 1beta and hypoxia cooperatively induce the expression of adrenomedullin in ovarian carcinoma cells through hypoxia inducible factor 1 activation. Cancer Res. 2005, 65 (11): 4690-4697. 10.1158/0008-5472.CAN-04-3877.CrossRefPubMedGoogle Scholar
- 27.Oda S, Oda T, Nishi K, Takabuchi S, Wakamatsu T, Tanaka T, Adachi T, Fukuda K, Semenza GL, Hirota K: Macrophage migration inhibitory factor activates hypoxia-inducible factor in a p53-dependent manner. PLoS One. 2008, 3 (5): e2215-10.1371/journal.pone.0002215.PubMedCentralCrossRefPubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.